迈克生物,300463,收入构成,报告日期,2019-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 体外诊断产品,322296,155295,167001,51.82%,100% 迈克生物,300463,收入构成,报告日期,2018-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 体外诊断产品,268530,129428,139102,51.8%,100% 迈克生物,300463,收入构成,报告日期,2017-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 体外诊断产品,196998,91102,105896,53.75%,100% 迈克生物,300463,收入构成,报告日期,2016-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2033,166,1867,91.84%,2.32% 商业,88248,53224,35024,39.69%,43.49% 工业,58596,14951,43646,74.49%,54.19% 迈克生物,300463,收入构成,报告日期,2016-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),968,170,798,82.41%,2.2% 代理仪器,6067,4683,1384,22.82%,3.81% 代理试剂,34477,19409,15069,43.71%,41.47% 自产仪器,477,346,131,27.53%,0.36% 自产试剂,24912,5957,18955,76.09%,52.16% 迈克生物,300463,收入构成,报告日期,2015-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),823,104,719,87.4%,1.18% 商业,53355,29777,23579,44.19%,38.86% 工业,52339,15960,36379,69.51%,59.96% 迈克生物,300463,收入构成,报告日期,2015-06-30, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理试剂,20945,10269,10675,50.97%,36.83% 其他(补充),301,61,240,79.67%,0.83% 自产仪器,3442,2351,1091,31.7%,3.76% 代理仪器,5461,4201,1261,23.09%,4.35% 自产试剂,21293,5574,15719,73.82%,54.23% 迈克生物,300463,收入构成,报告日期,2015-03-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 商业,11432,6150,5282,46.2%,45.02% 其他(补充),111,22,90,80.57%,0.76% 工业,9277,2916,6362,68.57%,54.22% 迈克生物,300463,收入构成,报告日期,2014-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1530,163,1367,89.35%,2.47% 商业,50468,25828,24640,48.82%,44.48% 工业,41487,12101,29385,70.83%,53.05% 迈克生物,300463,收入构成,报告日期,2013-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1159,146,1013,87.38%,2.31% 商业,45300,24287,21013,46.39%,47.83% 工业,31484,9580,21904,69.57%,49.86% 迈克生物,300463,收入构成,报告日期,2012-12-31, 按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比 工业,23129,6993,16135,69.76%,47.49% 其他(补充),894,170,723,80.96%,2.13% 商业,36593,19477,17116,46.77%,50.38%